Liposomal Amikacin Inhalation Suspension-induced Pneumonitis

Intern Med. 2022 Aug 15;61(16):2547-2549. doi: 10.2169/internalmedicine.8796-21. Epub 2022 Feb 1.

Authors

Moe Kidogawa¹, Kei Yamasaki¹, Kazuki Nemoto¹, Kazuhiro Yatera¹

Affiliation

¹ Department of Respiratory Medicine, University of Occupational and Environmental Health, Japan.

No abstract available

Keywords: Mycobacterium avium complex; amikacin liposome inhalation suspension; non-tuberculous mycobacteria.

MeSH terms

Administration, Inhalation
Amikacin / adverse effects
Anti-Bacterial Agents / therapeutic use
Humans
Liposomes / therapeutic use
Microbial Sensitivity Tests
Mycobacterium avium Complex
Mycobacterium avium-intracellulare Infection* / drug therapy
Pneumonia* / drug therapy

Substances

Anti-Bacterial Agents
Liposomes
Amikacin